Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuromuscular disease caused by the qualitative or quantitative defects of plectin. It is characterized by muscular dystrophy.
Biomarker and diagnostic research for neuromuscular disease caused by qualitative or quantitative defects of plectin has been reported in the published literature.
No clinical trials have been registered for neuromuscular disease caused by qualitative or quantitative defects of plectin.
129 publications have been identified in PubMed for neuromuscular disease caused by qualitative or quantitative defects of plectin. Research spans Other (53%), Basic Science / Preclinical (20%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Other research | 69 | 53% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:31 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
26 |
20% |
Research summaries | 17 | 13% |
Testing and diagnosis research | 5 | 4% |
Disease patterns and progression | 5 | 4% |
Patient case studies | 3 | 2% |
Clinical study results | 2 | 2% |
New treatment approaches | 2 | 2% |
Kramarz C (2026). [PMID: 42231561](https://pubmed.ncbi.nlm.nih.gov/42231561/). *J Peripher Nerv Syst*. [Epidemiology / Natural History]
Allergodt K (2026). [PMID: 40842110](https://pubmed.ncbi.nlm.nih.gov/40842110/). *Disabil Rehabil*. [Other]
van der Laan TMJ (2026). [PMID: 41973741](https://pubmed.ncbi.nlm.nih.gov/41973741/). *PLoS One*. [Epidemiology / Natural History]
Demirkol H (2026). [PMID: 41124361](https://pubmed.ncbi.nlm.nih.gov/41124361/). *J Back Musculoskelet Rehabil*. [Other]
Paroli M (2026). [PMID: 41432692](https://pubmed.ncbi.nlm.nih.gov/41432692/). *J Neurophysiol*. [Other]
Zhang T (2026). [PMID: 40506408](https://pubmed.ncbi.nlm.nih.gov/40506408/). *Journal of clinical nursing*. [Review / Meta-Analysis]
Schoser B (2026). [PMID: 41689635](https://pubmed.ncbi.nlm.nih.gov/41689635/). *Journal of neurology*. [Gene Therapy / Novel Therapeutics]
Jose A (2026). [PMID: 41999517](https://pubmed.ncbi.nlm.nih.gov/41999517/). *Neurogenetics*. [Other]
Renou S (2026). [PMID: 40763243](https://pubmed.ncbi.nlm.nih.gov/40763243/). *Menopause*. [Other]
Ishii Y (2026). [PMID: 41447267](https://pubmed.ncbi.nlm.nih.gov/41447267/). *Int J Qual Stud Health Well-being*. [Other]